Physician profile
Christopher Michael Collins
NPI 1205807591
$3,847.66
in general payments reported to CMS, 2019-2025
16 companies · $805 in 2025
The $805 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $951 · 2020: $80.67 · 2021: $67.18 · 2022: $459 · 2023: $795 · 2024: $690 · 2025: $805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,110 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,110.12 |
| Education | $179.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,203.06 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $776.43 | 2023-2025 | Dupixent |
| Optinose US, INC. | $554.12 | 2019-2025 | |
| Acclarent, INC | $275.85 | 2019-2023 | Acclarent Aera, Trudi Nav Cable |
| Stryker Corporation | $202.54 | 2019-2025 | Neptune |
| Intersect Ent, INC. | $201.07 | 2019 | |
| Smith+Nephew, INC. | $191.39 | 2019-2022 | |
| Aerin Medical INC. | $147.09 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $99.99 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $58.90 | 2025 | Tezspire |
| Kaleo, INC. | $42.07 | 2021-2022 | |
| Glaxosmithkline, LLC. | $27.50 | 2025 | Nucala |
| Novo Nordisk INC | $26.67 | 2022 | |
| Hikma Pharmaceuticals USA | $14.72 | 2025 | Ryaltris |
| Pfizer INC. | $14.28 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.